|1.||Smit, Derrick P: 1 article (11/2010)|
|2.||Santo, Ronel N: 1 article (10/2005)|
|3.||Eggenberger, Eric R: 1 article (10/2005)|
|4.||Antonio-Santos, Aileen A: 1 article (10/2005)|
|5.||Savino, P: 1 article (04/2004)|
|6.||Danesh-Meyer, H V: 1 article (04/2004)|
|7.||Sergott, R: 1 article (04/2004)|
|8.||Galiani, David: 1 article (03/2003)|
|9.||Moster, Mark L: 1 article (03/2003)|
|10.||Garfinkle, William: 1 article (03/2003)|
07/15/1990 - "Thus, the variability of hydroxyamphetamine mydriasis from one eye to the other in a single subject was much lower than the variability between subjects."
07/15/1990 - "Hydroxyamphetamine mydriasis in normal subjects."
06/01/1980 - "The failure of hydroxyamphetamine to cause mydriasis indicates damage to the postganglionic sympathetic neuron, but in the neonate this damage may be secondary to a preganglionic lesion."
12/15/1990 - "Hydroxyamphetamine mydriasis in normal subjects and hydroxyamphetamine mydriasis in Horner's syndrome."
07/15/1990 - "Hydroxyamphetamine mydriasis in Horner's syndrome."
|2.||Horner Syndrome (Horner's Syndrome)
03/01/2003 - "However, the hydroxyamphetamine test may be positive even after the ophthalmic signs of Horner syndrome have disappeared."
08/01/2001 - "Hydroxyamphetamine drops for Horner's syndrome."
01/01/2000 - "A right, third-order neuron Horner's syndrome was confirmed with 1% hydroxyamphetamine topical drops. "
12/01/1996 - "Two patients with acute unilateral Horner's syndrome whose pupils initially dilated equally to hydroxyamphetamine had pharmacologic localization to the postganglionic nerve in the second week following the onset of symptoms. "
08/01/1982 - "Hydroxyamphetamine appears to be a diagnostically useful drug in Horner's syndrome."
09/01/1989 - "In this double-masked clinical study, we evaluated four concentrations of tropicamide (0.05%, 0.1%, 0.25%, and 0.5%) combined with hydroxyamphetamine 1% to find the combination that gives maximal pupillary dilation and inhibition of responsiveness to light and minimal paralysis of accommodation. "
11/01/2010 - "For more than three decades, topical cocaine has been used to confirm the diagnosis and hydroxyamphetamine to localise the causative lesion in oculosympathetic palsy or Horner's syndrome. "
06/01/1988 - "Pupillometrically, there was thus a Horner-like syndrome on the right (non-symptomatic) side, with miosis and a relatively more marked dilatation of that eye subsequent to topical application of a directly working sympathomimetic agent (phenylephrine) than after an indirectly working one (hydroxyamphetamine), whereas this was not the case on the symptomatic side. "
01/01/1994 - "Near total unilateral ocular sympathetic denervation was confirmed by ipsilateral miosis, supersensitivity of pupillary dilatation to topical phenylephrine and pupillary hyporesponsiveness to topical hydroxyamphetamine. "
01/01/1992 - "Unilateral ocular sympathetic denervation persisting for at least 2 yr was confirmed by ipsilateral ptosis, miosis, supersensitivity of pupillary dilation to topical phenylephrine, and profound pupillary hyporesponsiveness to topical hydroxyamphetamine. "
02/01/1983 - "The small pupil was found to be supersensitive to the mydriatic effect of topical 2% phenylephrine but normally sensitive to 0.5% hydroxyamphetamine eyedrops. "
|2.||Cocaine (Cocaine HCl)
|5.||Ophthalmic Solutions (Eye Drops)